| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |